About armata pharmaceuticals - ARMP
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.
ARMP At a Glance
Armata Pharmaceuticals, Inc.
5005 McConnell Avenue
Los Angeles, California 90066
| Phone | 1-310-665-2928 | Revenue | 4.90M | |
| Industry | Biotechnology | Net Income | -173,799,000.00 | |
| Sector | Health Technology | Employees | 61 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
ARMP Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 46.408 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -17.073 |
| Enterprise Value to Sales | 103.367 |
| Total Debt to Enterprise Value | 0.568 |
ARMP Efficiency
| Revenue/Employee | 80,393.443 |
| Income Per Employee | -2,849,163.934 |
| Receivables Turnover | 10.39 |
| Total Asset Turnover | 0.053 |
ARMP Liquidity
| Current Ratio | 1.192 |
| Quick Ratio | 1.192 |
| Cash Ratio | 0.971 |
ARMP Profitability
| Gross Margin | 68.781 |
| Operating Margin | -636.664 |
| Pretax Margin | -3,544.025 |
| Net Margin | -3,544.025 |
| Return on Assets | -187.363 |
| Return on Equity | N/A |
| Return on Total Capital | -250.351 |
| Return on Invested Capital | -347.706 |
ARMP Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 414.88 |
| Total Debt to Total Assets | 334.17 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 408.306 |